GTF2IRD1
GTF2IRD1 (GTF2I repeat domain containing 1) is a nuclear member of the TFII-I family that is thought to regulate transcription. It is also known as MusTRD1, RBAP2, GTF3, WBSCR12, BEN, Cream1 and WBSCR11. Browse Assay Genie's current range of GTF2IRD1 research reagents below, or read on for the biology behind the target.
GTF2IRD1 may act as a transcription regulator involved in cell-cycle progression and skeletal muscle differentiation. It binds the troponin I slow-muscle fibre enhancer (USE B1) and binds specifically and with high affinity to the EFG sequences derived from the early enhancer of HOXC8. It may contribute to slow-twitch fibre type specificity during myogenesis and in regenerating muscles. It may also repress the transcriptional functions of GTF2I, either by preventing its nuclear residency or by inhibiting its transcriptional activation.
The GTF2IRD1 protein contains five GTF2I-like repeats, and each repeat carries a potential helix-loop-helix (HLH) motif. This suggests it may interact with other HLH proteins and function as a transcription factor, or as a positive transcriptional regulator under the control of Retinoblastoma protein. The protein is localised to the nucleus and belongs to the TFII-I family. The human GTF2IRD1 gene lies at 7q11.23, and alternative splicing results in multiple transcript variants. The mouse ortholog is Gtf2ird1.
The gene has been known under several names, including MusTRD1, RBAP2, GTF3, WBSCR12, BEN, Cream1 and WBSCR11. GTF2IRD1 plays a role in craniofacial and cognitive development. Mutations have been associated with Williams-Beuren syndrome, a multisystem developmental disorder caused by deletion of multiple genes at 7q11.23, which makes it a frequent subject in studies of this condition.
GTF2IRD1 lies in the 7q11.23 region deleted in Williams-Beuren syndrome, a multisystem developmental disorder, and is linked to the condition.
The GTF2IRD1 gene plays a role in craniofacial and cognitive development, making it relevant to developmental biology studies.
GTF2IRD1 may regulate skeletal muscle differentiation and contribute to slow-twitch fibre specificity during myogenesis and in regenerating muscle.
GTF2IRD1 binds the USE B1 and HOXC8 enhancer sequences and may modulate GTF2I activity, offering a model for TFII-I family regulation.
GTF2IRD1 may be a transcription regulator involved in cell-cycle progression and skeletal muscle differentiation. It binds the troponin I slow-muscle fibre enhancer USE B1 and the EFG sequences of the early HOXC8 enhancer, and may repress GTF2I transcriptional functions.
GTF2IRD1 is also called MusTRD1, RBAP2, GTF3, WBSCR12, BEN, Cream1 and WBSCR11. Its full name is GTF2I repeat domain containing 1. Alternative splicing produces multiple transcript variants, so a single gene can give rise to more than one transcript.
Mutations in GTF2IRD1 have been associated with Williams-Beuren syndrome, a multisystem developmental disorder caused by deletion of multiple genes at 7q11.23. The gene plays a role in craniofacial and cognitive development. A mouse ortholog, Gtf2ird1, exists; check the datasheet of any product for its validated reactivity.
GTF2I, which GTF2IRD1 may repress, and other general transcription factor targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9UHL9; product specifications from Assay Genie datasheets.